Prostate-specific membrane antigen (PSMA) is glutamate carboxypeptidase II (GCPII) that is overexpressed on the surface of prostate cancer cells and plays a vital role in prostate carcinogenesis and the malignancy of the disease [5,6]. The gene discussed is FOLH1; the disease is medical procedure.